Combination of Nicorandil and Beta-Adrenergic Receptor Blockers in Patients with Coronary Artery Disease: A Real-World Observational Study.

Jia ChengLin QiuZixuan ZhangNa LiHongyang ShuZhichao XiaoNing Zhou

Published in: Journal of cardiovascular pharmacology and therapeutics (2023)

A combined antiangina treatment of nicorandil and BBs may be more effective than treatment of BBs alone in reducing the long-term incidence of MACE in patients with CAD.

Keyphrases

coronary artery disease
combination therapy
binding protein